US Patent 10532042 KRAS G12C inhibitors and methods of using the same

Is a

Patent

Patent attributes

Patent Applicant

Amgen

Current Assignee

Amgen

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

105320420

Patent Inventor Names

Shon Booker0

Victor J. Cee0

Alexander J. Pickrell0

Anthony B. Reed0

Brian Alan Lanman0

Christopher M. Tegley0

David John Kopecky0

Hui-Ling Wang0

...

Date of Patent

January 14, 2020

Patent Application Number

158499050

Date Filed

December 21, 2017

Patent Citations Received

‌

US Patent 12122787 Fused pyridone compound, and preparation method therefor and use thereof

‌

US Patent 11053226 KRAS G12C inhibitors and methods of using the same

‌

US Patent 11285135 KRAS G12C inhibitors and methods of using the same

‌

US Patent 11285156 Substituted piperazines as KRAS G12C inhibitors

‌

US Patent 11299491 Synthesis of key intermediate of KRAS G12C inhibitor compound

‌

US Patent 11306087 Inhibitors of KRAS G12C and methods of using the same

‌

US Patent 11766436 KRAS G12C inhibitors and methods of using the same

‌

US Patent 11426404 Dosing of

...

Patent Primary Examiner

‌

Brian E McDowell

Patent abstract

Provided herein are KRAS G12C inhibitors, compounds of formula (II), or a pharmaceutically acceptable salt thereof:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 10532042 KRAS G12C inhibitors and methods of using the same

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 10532042 KRAS G12C inhibitors and methods of using the same